Is Consolidation Necessary to Spark a Major New Wave of Biotech Innovation?

As mergers between the major seed and crop protection players move forward, I wanted to share two major lenses on how I think about these developments. These are not meant to be conclusive opinions, but rather thoughts on how to look at different sides of the same coin. I’ll share the “beneficial” lense this week, and the “skeptical” lense next week.

Gene manipulation

Consolidation is Necessary to Spark a Major New Wave of Biotech Innovation

Although GM technology has been commercialized for over two decades, the precision and exactitude of changing genetic material in plants and other organisms is only now starting to be mastered. Initial GM technology, described simply, bombarded plant DNA with foreign DNA by applying radiation and other gene manipulation methods in the hope that the foreign DNA would “stick” to the gene and be stable across subsequent generations of plants.

As plant breeding and GM technology evolved, plant biologists learned to more quickly identify DNA markers of a successful gene transfer, test if certain seeds contained the properly inserted genes without having to either grow the plant to full maturity or destroy the seed, and better predict how various genes were likely to interact and express themselves as part of a full-grown plant. However, despite these incredible scientific advances, at its core, it’s possible to argue that GM technology remains relatively “young”.

Fast-forward to today, the emergence of direct gene manipulation technologies like CRISP/cas9 and its equivalents, dramatic reductions in gene sequencing costs, large data sets of agronomic performance in real-world (field settings), and an emerging understanding of how plants interact with many other organisms (fungi, insects, microbes) suggest that biology and data are on a giant collision course with promising potential applications.

Non-browning apple

Early GM was about relatively rudimentary applications, focused on combating weeds or pests. New GM technologies suggest we can optimize plants for other things – so-called output traits (non-browning Arctic apples, better frying Innate potatoes, etc.), or even other productivity traits (drought resistance). If we move beyond the plant, by harnessing and optimizing other living things that interact with the plant and using data to optimize plant growing conditions – the possibilities seem endless.

The practical application and success of this technology is by no means a slam dunk.  There are so many factors at play (think crops, microbes, soil, weather, and the farmer all influencing each other) that developing practical solutions for farmers from these theoretical optimizations is perhaps at worst, a agronomist’s fantasy, and at best, very expensive and complex to develop. However, the potential of the technology is huge.

The consolidation of R&D powerhouses (like Monsanto and Bayer) may be necessary to spark a major new wave of biotech innovation. Specifically, the ability to spread out the cost of all the R&D expenses associated with not only plant breeding and gene manipulation, but also potentially other organism optimizations, as well as acquiring, compiling and analyzing agronomic performance data may indeed only be possible if done by a few major agriculture players with the wherewithal to take on such R&D costs, timelines and risk.

Pushing this thinking, one can even argue that monopolies may not be a bad thing. But that’s only one side of the story… more on this next week.

About the Author
Alain Goubau

After growing up on dairy and cash crop farm in Eastern Ontario, Alain would go on to conduct  global agriculture strategy projects with McKinsey & Company’s Agriculture Practice. Fluent in French, English and Spanish, he holds a Bachelor of Engineering from McGill University and a Juris Doctor from Harvard Law School.

Most Recent Posts
Dec. 12 - Anyone Notice Yesterday’s WASDE Report?
December 12, 2018 Brennan Turner
Grain prices are all in the green this morning as the complex rebounds from a relatively quiet WASDE report, albeit it was viewed as bearish.
October 4: Corn Prices Edge Higher With October WASDE in Focus
October 04, 2018 Garrett Baldwin
Corn prices ticked higher Thursday as traders and analysts began to speculate on next week’s release of the October WASDE report.